Solutions
We build privacy-by-design foundation AI models for genomics, trained on millions of EMR-linked healthcare records and a significant set of whole-genome sequences, turning Asia-diverse data into commercially impactful real-world evidence, digital twins, drug discovery insights, and accelerated clinical trials. With the genomic breadth others lack and the AI insights the world needs, our platform enables pharmaceutical, clinical, and MedTech partners to deploy compliant, scalable genomics AI—unlocking faster R&D, differentiated products, and defensible data advantages while meeting global privacy and regulatory standards.
RWE-based AI Suites
Advanced AI Technologies
01
Patient-Based Forecasting Engine
Predict which patients will start therapy, switch, discontinue, or respond based on genomics + real-world patterns – Difference between expected volume vs. actual.
03
Genomic Foundation AI Modules
Cloud-hosted or on-premise deployment. Batch processing or real-time inference.
02
Market Access Analytics Suite
RWE-linked clinical outcomes + health economics data to demonstrate value to Asian regulators and payers
04
Digital Twin for Trial Acceleration
Computationally simulate trial outcomes using real patient genomic + EMR data before enrolling a single patient